Authors:
Boros, LG
Lapis, K
Szende, B
Tomoskozi-Farkas, R
Balogh, A
Boren, J
Marin, S
Cascante, M
Hidvegi, M
Citation: Lg. Boros et al., Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells, PANCREAS, 23(2), 2001, pp. 141-147
Citation: Lg. Boros et al., Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: A new mechanism of controlling tumor growth, PANCREAS, 22(1), 2001, pp. 1-7
Authors:
Boren, J
Cascante, M
Marin, S
Comin-Anduix, B
Centelles, JJ
Lim, S
Bassilian, S
Ahmed, S
Lee, WNP
Boros, LG
Citation: J. Boren et al., Gleevec (ST1571) influences metabolic enzyme activities and glucose carbonflow toward nucleic acid and fatty acid synthesis in myeloid tumor cells, J BIOL CHEM, 276(41), 2001, pp. 37747-37753
Authors:
Comin-Anduix, B
Boren, J
Martinez, S
Moro, C
Centelles, JJ
Trebukhina, R
Petushok, N
Lee, WNP
Boros, LG
Cascante, M
Citation: B. Comin-anduix et al., The effect of thiamine supplementation on tumour proliferation - A metabolic control analysis study, EUR J BIOCH, 268(15), 2001, pp. 4177-4182
Citation: Lg. Boros, Population thiamine status and varying cancer rates between Western, Asianand African countries, ANTICANC R, 20(3B), 2000, pp. 2245-2248
Authors:
Boros, LG
Torday, JS
Lim, S
Bassilian, S
Cascante, M
Lee, WNP
Citation: Lg. Boros et al., Transforming growth factor beta(2) promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells, CANCER RES, 60(5), 2000, pp. 1183-1185
Authors:
Rais, B
Comin, B
Puigjaner, J
Brandes, JL
Creppy, E
Saboureau, D
Ennamany, R
Lee, WNP
Boros, LG
Cascante, M
Citation: B. Rais et al., Oxythiamine and dehydroepiandrosterone induce a G(1) phase cycle arrest inEhrlich's tumor cells through inhibition of the pentose cycle, FEBS LETTER, 456(1), 1999, pp. 113-118
Authors:
Fisher, WE
Muscarella, P
Boros, LG
Schirmer, WJ
Citation: We. Fisher et al., Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma, INT J PANCR, 24(3), 1998, pp. 169-180